|
Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics
|
1
|
Resverlogix Corp.
|
Jun 12, 2017 08:24PM
|
|
Re: Odd About The Disappearing Presentation
|
1
|
Resverlogix Corp.
|
May 22, 2017 11:17AM
|
|
Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:20PM
|
|
Re: More In Financial Post Today March 29
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2016 10:28AM
|
|
Dr. Mark Day interview with Proactive Investors at BIO CEO
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 12, 2019 07:47AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
1
|
Resverlogix Corp.
|
Mar 24, 2019 07:44PM
|
|
Re: News !!!
|
1
|
Resverlogix Corp.
|
Feb 26, 2018 02:04PM
|
|
At least RVX has a shorter trial timeline than ESPR
|
1
|
Resverlogix Corp.
|
May 05, 2016 12:10PM
|
|
Re: Is there a market for low LDL
|
1
|
Resverlogix Corp.
|
Feb 18, 2020 09:39PM
|
|
Re: Primate/Monkey Studies / Financing
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 07, 2019 12:42PM
|
|
Re: what a humble board looks like ..
|
1
|
Resverlogix Corp.
|
Sep 12, 2016 01:24PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
1
|
Resverlogix Corp.
|
Jun 14, 2019 03:42PM
|
|
Re: HDL from an Alzheimer's disease perspective
|
1
|
Resverlogix Corp.
|
Jun 27, 2019 10:22AM
|
|
Re: March Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 29, 2021 07:34AM
|
|
Re: Resverlogix BIO CEO & Investor Conference 2017 Slides
|
1
|
Resverlogix Corp.
|
Feb 15, 2017 01:49PM
|
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 08:32AM
|
|
Re: Trial
|
1
|
Zenith Epigenetics
|
Dec 10, 2019 09:20PM
|
|
Post from Fouremm on the other board
|
1
|
Resverlogix Corp.
|
Aug 13, 2015 11:03AM
|
|
Re: Corporate Update on Monday, June 19, 2017
|
1
|
Resverlogix Corp.
|
Jun 12, 2017 10:04PM
|
|
Epizyme shares slump as cancer drug data update disappoints
|
1
|
Zenith Epigenetics
|
Jun 14, 2017 11:16AM
|
